万泰生物：截至目前，公司二价HPV疫苗已在安哥拉、巴基斯坦、白俄罗斯等海外国家实现销售

Core Insights - The company has successfully sold its bivalent HPV vaccine in multiple overseas markets including Angola, Pakistan, Belarus, Cuba, Madagascar, Nicaragua, Nepal, El Salvador, Thailand, Tunisia, and Guatemala [1] Summary by Categories - Product Development - The bivalent HPV vaccine has achieved sales in various international markets, indicating successful product penetration and acceptance [1] - Market Expansion - The company has expanded its market reach to 11 countries, showcasing its international growth strategy and potential for further expansion [1]